CELLARITY - Trademark Details
Status: 700 - Registered
Serial Number
88285561
Registration Number
6059746
Word Mark
CELLARITY
Status
700 - Registered
Status Date
2020-05-19
Filing Date
2019-02-01
Registration Number
6059746
Registration Date
2020-05-19
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-07-02
Attorney Name
Law Office Assigned Location Code
N30
Employee Name
DANG, PETER T
Statements
Goods and Services
Software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for drug discovery and development; research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks
Goods and Services
Providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; Providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; Providing on-line nondownloadable software featuring machine learning and artificial intelligence for drug analysis, namely, drug discovery and development; Scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; Providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-02-24
Primary Code
042
First Use Anywhere Date
2019-12-16
First Use In Commerce Date
2019-12-16
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Christina M. Licursi
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0097921
Original Filing Date USPTO
2020-07-01
International Registration Number
1544238
International Registration Date
2020-07-01
International Status Code
480
International Renewal Date
2030-07-01
Madrid History Events | ||
Date | Code | Description |
2020-07-01 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
2020-07-01 | ACERT | AUTOMATICALLY CERTIFIED |
2020-07-01 | APPST | IR CERTIFIED AND SENT TO IB |
2020-08-06 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
Trademark Events
Event Date | Event Description |
2019-02-24 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-04-15 | ASSIGNED TO EXAMINER |
2019-04-15 | NON-FINAL ACTION WRITTEN |
2019-04-15 | NON-FINAL ACTION E-MAILED |
2019-04-15 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-05-14 | EXAMINERS AMENDMENT -WRITTEN |
2019-05-14 | EXAMINERS AMENDMENT E-MAILED |
2019-05-14 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2019-05-14 | EXAMINER'S AMENDMENT ENTERED |
2019-05-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-05-29 | ASSIGNED TO LIE |
2019-06-12 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-07-02 | PUBLISHED FOR OPPOSITION |
2019-07-02 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-08-27 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-02-27 | TEAS EXTENSION RECEIVED |
2020-02-27 | EXTENSION 1 FILED |
2020-02-27 | EXTENSION 1 GRANTED |
2020-02-29 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-03-18 | TEAS STATEMENT OF USE RECEIVED |
2020-04-04 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-03-18 | USE AMENDMENT FILED |
2020-04-04 | STATEMENT OF USE PROCESSING COMPLETE |
2020-04-13 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2020-04-14 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2020-05-19 | REGISTERED-PRINCIPAL REGISTER |
2021-12-28 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2021-12-28 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-12-28 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-12-28 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-12-28 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |